Does Dr. SCOTT BUCHANAN have financial conflicts of interest?

Dr. SCOTT BUCHANAN (M.D.) has received a total of $10,444 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $10,444 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. SCOTT BUCHANAN?

According to CMS Open Payments data, Dr. SCOTT BUCHANAN received funding from EDWARDS LIFESCIENCES CORPORATION ($3,542), ARTIVION ($2,038), and ABBOTT LABORATORIES ($1,994).

Does Dr. SCOTT BUCHANAN receive research grants or speaking fees?

Dr. SCOTT BUCHANAN has received $10,444 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. SCOTT BUCHANAN

M.D.Real-Time Hydrated

Specialty: Thoracic Surgery (Cardiothoracic Vascular Surgery)

Practice Location: PORTLAND, ME 04102

NPI Number: 1932154135

LIFETIME INDUSTRY VALUE

$10,444

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. BUCHANAN is a verified Thoracic Surgery (Cardiothoracic Vascular Surgery) practitioner based in PORTLAND, ME.

Between 2021 and 2025, Dr. BUCHANAN had an overall industry promotional and research financial footprint of $10,444 as recorded in the federal CMS Open Payments database.

$10,444 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BUCHANAN's primary funding source is EDWARDS LIFESCIENCES CORPORATION, which accounts for $3,542 (representing 33.9% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

EDWARDS LIFESCIENCES CORPORATION

Rank 1

$3,542

33.9%

ARTIVION

Rank 2

$2,038

19.5%

ABBOTT LABORATORIES

Rank 3

$1,994

19.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.